Herpes Labialis Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 67 pages | ID: HA2AEB354058EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Herpes Labialis Treatment in Global, including the following market information:

Global Herpes Labialis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Herpes Labialis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Acyclovir Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Herpes Labialis Treatment include Teva, Abbott, Sun, Mylan, Pfizer, GlaxoSmithKline, Dr. Reddy's and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herpes Labialis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Herpes Labialis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Herpes Labialis Treatment Market Segment Percentages, by Type, 2021 (%)

• Acyclovir
• Valacyclovir
• Famciclovir
• Penciclovir
• Docosanol

Global Herpes Labialis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Herpes Labialis Treatment Market Segment Percentages, by Application, 2021 (%)

• Topical
• Oral

Global Herpes Labialis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Herpes Labialis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Herpes Labialis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Herpes Labialis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• Abbott
• Sun
• Mylan
• Pfizer
• GlaxoSmithKline
• Dr. Reddy's
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Herpes Labialis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Herpes Labialis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HERPES LABIALIS TREATMENT OVERALL MARKET SIZE

2.1 Global Herpes Labialis Treatment Market Size: 2021 VS 2028
2.2 Global Herpes Labialis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Herpes Labialis Treatment Players in Global Market
3.2 Top Global Herpes Labialis Treatment Companies Ranked by Revenue
3.3 Global Herpes Labialis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Herpes Labialis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Herpes Labialis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Herpes Labialis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Herpes Labialis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Herpes Labialis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Herpes Labialis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Acyclovir
  4.1.3 Valacyclovir
  4.1.4 Famciclovir
  4.1.5 Penciclovir
  4.1.6 Docosanol
4.2 By Type - Global Herpes Labialis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Herpes Labialis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Herpes Labialis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Herpes Labialis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Herpes Labialis Treatment Market Size, 2021 & 2028
  5.1.2 Topical
  5.1.3 Oral
5.2 By Application - Global Herpes Labialis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Herpes Labialis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Herpes Labialis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Herpes Labialis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Herpes Labialis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Herpes Labialis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Herpes Labialis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Herpes Labialis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Herpes Labialis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Herpes Labialis Treatment Revenue, 2017-2028
  6.3.2 US Herpes Labialis Treatment Market Size, 2017-2028
  6.3.3 Canada Herpes Labialis Treatment Market Size, 2017-2028
  6.3.4 Mexico Herpes Labialis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Herpes Labialis Treatment Revenue, 2017-2028
  6.4.2 Germany Herpes Labialis Treatment Market Size, 2017-2028
  6.4.3 France Herpes Labialis Treatment Market Size, 2017-2028
  6.4.4 U.K. Herpes Labialis Treatment Market Size, 2017-2028
  6.4.5 Italy Herpes Labialis Treatment Market Size, 2017-2028
  6.4.6 Russia Herpes Labialis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Herpes Labialis Treatment Market Size, 2017-2028
  6.4.8 Benelux Herpes Labialis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Herpes Labialis Treatment Revenue, 2017-2028
  6.5.2 China Herpes Labialis Treatment Market Size, 2017-2028
  6.5.3 Japan Herpes Labialis Treatment Market Size, 2017-2028
  6.5.4 South Korea Herpes Labialis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Herpes Labialis Treatment Market Size, 2017-2028
  6.5.6 India Herpes Labialis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Herpes Labialis Treatment Revenue, 2017-2028
  6.6.2 Brazil Herpes Labialis Treatment Market Size, 2017-2028
  6.6.3 Argentina Herpes Labialis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Herpes Labialis Treatment Revenue, 2017-2028
  6.7.2 Turkey Herpes Labialis Treatment Market Size, 2017-2028
  6.7.3 Israel Herpes Labialis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Herpes Labialis Treatment Market Size, 2017-2028
  6.7.5 UAE Herpes Labialis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva
  7.1.1 Teva Corporate Summary
  7.1.2 Teva Business Overview
  7.1.3 Teva Herpes Labialis Treatment Major Product Offerings
  7.1.4 Teva Herpes Labialis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Teva Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott Herpes Labialis Treatment Major Product Offerings
  7.2.4 Abbott Herpes Labialis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Abbott Key News
7.3 Sun
  7.3.1 Sun Corporate Summary
  7.3.2 Sun Business Overview
  7.3.3 Sun Herpes Labialis Treatment Major Product Offerings
  7.3.4 Sun Herpes Labialis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Sun Key News
7.4 Mylan
  7.4.1 Mylan Corporate Summary
  7.4.2 Mylan Business Overview
  7.4.3 Mylan Herpes Labialis Treatment Major Product Offerings
  7.4.4 Mylan Herpes Labialis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Mylan Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Herpes Labialis Treatment Major Product Offerings
  7.5.4 Pfizer Herpes Labialis Treatment Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 GlaxoSmithKline
  7.6.1 GlaxoSmithKline Corporate Summary
  7.6.2 GlaxoSmithKline Business Overview
  7.6.3 GlaxoSmithKline Herpes Labialis Treatment Major Product Offerings
  7.6.4 GlaxoSmithKline Herpes Labialis Treatment Revenue in Global Market (2017-2022)
  7.6.5 GlaxoSmithKline Key News
7.7 Dr. Reddy's
  7.7.1 Dr. Reddy's Corporate Summary
  7.7.2 Dr. Reddy's Business Overview
  7.7.3 Dr. Reddy's Herpes Labialis Treatment Major Product Offerings
  7.7.4 Dr. Reddy's Herpes Labialis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Dr. Reddy's Key News
7.8 Novartis
  7.8.1 Novartis Corporate Summary
  7.8.2 Novartis Business Overview
  7.8.3 Novartis Herpes Labialis Treatment Major Product Offerings
  7.8.4 Novartis Herpes Labialis Treatment Revenue in Global Market (2017-2022)
  7.8.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Herpes Labialis Treatment Market Opportunities & Trends in Global Market
Table 2. Herpes Labialis Treatment Market Drivers in Global Market
Table 3. Herpes Labialis Treatment Market Restraints in Global Market
Table 4. Key Players of Herpes Labialis Treatment in Global Market
Table 5. Top Herpes Labialis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Herpes Labialis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Herpes Labialis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Herpes Labialis Treatment Product Type
Table 9. List of Global Tier 1 Herpes Labialis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Herpes Labialis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Herpes Labialis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Herpes Labialis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Herpes Labialis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Herpes Labialis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Herpes Labialis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Herpes Labialis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Herpes Labialis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Herpes Labialis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Herpes Labialis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Herpes Labialis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Herpes Labialis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Herpes Labialis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Herpes Labialis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Herpes Labialis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Teva Corporate Summary
Table 31. Teva Herpes Labialis Treatment Product Offerings
Table 32. Teva Herpes Labialis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott Herpes Labialis Treatment Product Offerings
Table 35. Abbott Herpes Labialis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Sun Corporate Summary
Table 37. Sun Herpes Labialis Treatment Product Offerings
Table 38. Sun Herpes Labialis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Mylan Corporate Summary
Table 40. Mylan Herpes Labialis Treatment Product Offerings
Table 41. Mylan Herpes Labialis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Herpes Labialis Treatment Product Offerings
Table 44. Pfizer Herpes Labialis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline Corporate Summary
Table 46. GlaxoSmithKline Herpes Labialis Treatment Product Offerings
Table 47. GlaxoSmithKline Herpes Labialis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Dr. Reddy's Corporate Summary
Table 49. Dr. Reddy's Herpes Labialis Treatment Product Offerings
Table 50. Dr. Reddy's Herpes Labialis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Herpes Labialis Treatment Product Offerings
Table 53. Novartis Herpes Labialis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Herpes Labialis Treatment Segment by Type in 2021
Figure 2. Herpes Labialis Treatment Segment by Application in 2021
Figure 3. Global Herpes Labialis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Herpes Labialis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Herpes Labialis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Herpes Labialis Treatment Revenue in 2021
Figure 8. By Type - Global Herpes Labialis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Herpes Labialis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Herpes Labialis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Herpes Labialis Treatment Revenue Market Share, 2017-2028
Figure 12. US Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Herpes Labialis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Herpes Labialis Treatment Revenue Market Share, 2017-2028
Figure 24. China Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Herpes Labialis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Herpes Labialis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Herpes Labialis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Herpes Labialis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Herpes Labialis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sun Herpes Labialis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Mylan Herpes Labialis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Herpes Labialis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline Herpes Labialis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dr. Reddy's Herpes Labialis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Herpes Labialis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)